FDA Approves Next-Gen mt-sDNA test, Cologuard Plus

The FDA has approved the next-generation of the multitarget stool DNA test Cologuard (Exact Sciences).

OCTOBER 9, 2024

Increased Cancer, Death Risks After Adenomas Found at Baseline

Long-term follow-up has documented a significantly increased incidence of CRC in patients with any adenomas on ...

JULY 25, 2024

Colonic Lesion Detection After Stool Test, PPI Use and AI Bowel Prep Evaluation

In this month’s column, I cover three topics: detection rates after stool tests, inappropriate use of PPIs, ...

JULY 17, 2024

Loren Laine, MD, on DDW Sessions You Can’t Miss

Digestive Disease Week 2024 is just around the corner, this year being held in Washington, D.C. 

MAY 15, 2024

FDA Approves First mt-sRNA Test for CRC Screening in Average-Risk Adults

The FDA has approved the first multitarget stool RNA test for colorectal cancer screening in typical average-risk ...

MAY 10, 2024

Blood-Based Tests Will Be Game Changers For Cancer Screening

To meet the increased CRC screening demands, clinicians need to use all available modalities—including stool- ...

APRIL 1, 2024

Multitarget Stool DNA Has Similar Accuracy in Patients After Bariatric Sx

mt-sDNA testing is accurate in predicting advanced colorectal neoplasia in patients who have undergone bariatric ...

NOVEMBER 7, 2023

Early Pancreatic Cancer Detection Possible Via Stool Analysis

A new analysis found a possible role for fecal microbiota as potential biomarkers for early pancreatic cancer ...

APRIL 28, 2022

Colonoscopy Quality Improves With Knowledge of Positive DNA Stool Test

San Diego—When patients test positive on the multitarget stool DNA test Cologuard (Exact Sciences)—and ...

SEPTEMBER 15, 2016